Recalls

L A Weight Loss Recalls L A Hot Drinks Café Au Lait Because of Possible Health Risk


HORSHAM, PA–(ENEWSPF)–July 13, 2009 –  Weight Loss Services, LP of Horsham, PA is recalling 403 cases (16,120 selling units) of L A Hot Drinks Café Au Lait net weight 4.07oz, because one of the ingredients of the product has the potential to be contaminated with Salmonella.  The ingredient, an instant non-fat dry milk product, was manufactured by Plainview Milk Products Cooperative of Plainview, MN. and further processed by Associated Brands LP, Medina, NY.

Salmonella is an organism, which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.  Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain.  In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e. infected aneurysms), endocarditis and arthritis.  For more information on Salmonella, please visit the Centers for Disease Control and Prevention’s Website at http://www.cdc.gov.

L A Hot Drinks Café Au Lait was distributed to Georgia, Illinois, and Washington. Consumers would have purchased this product through L A Weight Loss Centers.

The product is packaged in retail boxes with a UPC Code of 55958-00365 on the back panel. The front of the box is printed with “L A Hot Drinks Café Au Lait”.  There are 7 envelopes per box.  The top of the box is printed with a “BEST BY”  lot code.  We are only recalling the following lot codes (other lots are not involved):

BEST BY 08/13/29
BEST BY 08/14/09
BEST BY 11/28/09
BEST BY 01/30/10
BEST BT 01/31/10

No illnesses have been reported to date.

Consumers who have purchased this product are urged to return it to the place of purchase for a full refund.  Consumers with questions may contact Weight Loss Service LP at 1-215-328-2073 Monday through Friday from 9am through 3pm EDT.

 

Source: fda.gov


ARCHIVES